Dr. Reddy's bribery probe closed by US SEC without charges
MLex Summary: Dr. Reddy's Laboratories, an Indian pharmaceutical firm with securities listed on US stock markets, said the US Securities and Exchange Commission has closed an investigation into potential violations of the...To view the full article, register now.
Already a subscriber? Click here to view full article